Dr Murray Esler (IDI Heart and Diabetes Institute, Melbourne, Australia) discusses Symplicity HTN-2: International, Multicenter, Prospective, Randomized, Controlled Trial of Endovascular Selective Renal Sympathetic Denervation for the Treatment of Hypertension with Dr Gabriel Steg. Filmed during AHA 2010 in Chicago, IL on November 14.